Spruce Biosciences segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Spruce Biosciences utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$15.75 | -$15.56 | -$14.58 | 6.30% | $602.00K | $200.00K | $0.00 | -100.00% | 11/10/2025 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$16.50 | -$20.25 | -$3.50 | 82.72% | $1.61M | $200.00K | $0.00 | -100.00% | 08/14/2025 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$21.00 | -$15.00 | -$24.00 | -60.00% | $2.02M | $500.00K | $0.00 | -100.00% | 05/06/2025 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$17.25 | -$15.00 | -$42.75 | -185.00% | $2.89M | $885.00K | $697.00K | -21.24% | 04/15/2025 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$22.50 | -$18.00 | -$15.75 | 12.50% | $3.07M | $1.49M | $602.00K | -59.60% | 11/11/2024 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$24.00 | -$22.50 | -$16.50 | 26.67% | $2.17M | $1.50M | $1.61M | 7.69% | 08/12/2024 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$30.00 | -$21.75 | -$21.00 | 3.45% | $1.96M | $1.16M | $2.02M | 74.14% | 05/13/2024 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$36.75 | -$29.25 | -$17.25 | 41.03% | $0.00 | $1.40M | $2.89M | 106.21% | 03/13/2024 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$36.00 | -$26.25 | -$22.50 | 14.29% | $0.00 | $1.50M | $3.07M | 104.87% | 11/13/2023 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$38.25 | $29.25 | -$24.00 | -182.05% | $0.00 | $820.00K | $2.17M | 164.02% | 08/14/2023 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$37.50 | -$27.00 | -$30.00 | -11.11% | $0.00 | $500.00K | $1.96M | 292.80% | 05/15/2023 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$29.25 | -$39.75 | -$36.75 | 7.55% | $0.00 | — | $0.00 | — | 03/16/2023 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$36.75 | -$39.75 | -$36.00 | 9.43% | $0.00 | — | $0.00 | — | 11/10/2022 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$37.50 | -$44.25 | -$38.25 | 13.56% | $0.00 | — | $0.00 | — | 08/10/2022 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$31.50 | -$34.50 | -$37.50 | -8.70% | $0.00 | — | $0.00 | — | 05/11/2022 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$29.25 | -$40.50 | -$29.25 | 27.78% | $0.00 | — | $0.00 | — | 03/14/2022 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | -$926.25 | -$49.50 | -$36.75 | 25.76% | $0.00 | — | $0.00 | — | 11/15/2021 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | — | -$34.50 | -$37.50 | -8.70% | — | — | $0.00 | — | 08/10/2021 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | — | -$35.25 | -$31.50 | 10.64% | — | — | $0.00 | — | 05/12/2021 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | — | -$44.25 | -$29.25 | 33.90% | — | — | $0.00 | — | 03/22/2021 | |
SPRB | SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. | — | — | -$926.25 | — | — | — | $0.00 | — | 11/18/2020 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $-14.58 | $-15.56 | 6.30 % |
| Q2 | 2025-08-14 | $-3.50 | $-20.25 | 82.7 % |
| Q1 | 2025-05-06 | $-24.00 | $-15.00 | -60.0 % |
| Q4 | 2025-04-15 | $-42.75 | $-15.00 | -185.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $0 | $200.00K | -100.0 % |
| Q2 | 2025-08-14 | $0 | $200.00K | -100.0 % |
| Q1 | 2025-05-06 | $0 | $500.00K | -100.0 % |
| Q4 | 2025-04-15 | $697.00K | $885.00K | -21.2 % |
Spruce Biosciences (SPRB) non ha ancora previsto report sulle performance. L'ultimo report sui risultati è stato pubblicato il novembre 10, 2025 per il Q3.
Spruce Biosciences (SPRB) non ha ancora in programma alcun report sugli utili. L'ultimo report sugli utili è stato pubblicato il novembre 10, 2025 per il Q3 e l'EPS effettivo è stato $-14.58, che superato la stima di $-15.56.
Spruce Biosciences (SPRB) non ha ancora pianificato alcun report sugli utili. L'ultimo report sugli utili è stato pubblicato il novembre 10, 2025 per il Q3 e i ricavi effettivi sono stati $0K, che mancato la stima di $200K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.